KRRO Stock Analysis: Buy, Sell, or Hold?
KRRO - Korro Bio, Inc. Common Stock
$10.28
-0.12 (-1.15%)
▼
5d:
-8.78%
30d:
-15.25%
90d:
+26.6%
HOLD
LOW Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 06, 2026
Smart Money Distribution
KRRO is up 8.9% this week, but smart money is buying puts. Top strike: $10 2026-04-17 with 443 OI. Put ratio: 100% View Scanner →
Strength: 9.4/10
Get Alerted When KRRO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: KRRO shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: KRRO shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: KRRO is currently trading at $10.28, which is considered oversold relative to its 30-day fair value range of $10.79 to $12.09.
Technical Outlook: Technically, KRRO is showing sideways momentum. Immediate support is located at $9.90, while resistance sits at $12.62.
Market Sentiment: KRRO has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (3th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $20.00 (+94.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, KRRO is showing sideways momentum. Immediate support is located at $9.90, while resistance sits at $12.62.
Market Sentiment: KRRO has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (3th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $20.00 (+94.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$10.79 -
$12.09
Company Quality Score
43/100
(HOLD)
Options IV Signal
3th percentile
(COMPLACENCY WARNING)
Volume Confirmation
HIGH
Confidence Score
66.7%
Protect Your Profits
Holding KRRO? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 3th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 94.6% below Wall St target ($20.00)
- CAUTION: Recommendation downgraded due to -8.8% 5-day decline
Fair Price Analysis
30-Day Fair Range
$10.79 -
$12.09
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$1.48
(14.4%)
Support & Resistance Levels
Support Level
$9.90
Resistance Level
$12.62
Current Trend
Sideways
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.35
Wall Street Target
$20.00
(+94.6%)
Revenue Growth (YoY)
-43.1%
Share & Embed Analysis
Last updated: March 30, 2026 5:56 PM ET
Data refreshes hourly during market hours. Next update: 6:56 PM
Data refreshes hourly during market hours. Next update: 6:56 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is KRRO showing a specific setup today?
Insider Activity (6 Months)
8
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Anthony A Jr. Florence
BUY
207100 shares
2026-03-10
Edward T Mathers
BUY
207100 shares
2026-03-10
Enterprise Associates 17…
BUY
207100 shares
2026-03-10
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$449 | 56 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$94 | 59 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 45 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$101 | 60 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$26 | 54 HOLD |
Advanced KRRO Option Strategies
Professional options setups generated by AI based on today's KRRO price and gamma walls.
